Delivery Order SPE2DB22D3301-SPE2DB24FY5XT
Award Date
5/1/24
Potential Completion Date
5/2/24
Potential Value
$46K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an award ID of SPE2DB20D3101|SPE2DB24FRWA0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty medication, with a ceiling value of $171,716.16. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is September 25, 2024. The contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,641.27, is a Delivery Order for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of July 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $80,684.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. The contract has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $14,804.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 30, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,167.21, is a Delivery Order with a Firm Fixed Price for the supply of STELARA 90 MG/ML SYRINGEML. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D3011|SPE2DB24FQ2PZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,750.05, is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty medication. This is a Firm Fixed Price Delivery Order contract with a completion date of July 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,742.03, is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract has a completion date of December 5, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,812.37, is for the procurement of STELARA 90 MG/ML syringes and has a delivery order contract type with a firm fixed price. The contract has an ultimate completion date of March 4, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM1K6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of STELARA 90 MG/ML syringes, a specialty medication, with a ceiling value of $19,099.88. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of December 30, 2024. It is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $27,832.62, is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of May 29, 2024. The contract is not designated under any set-aside program, indicating open competition. AmerisourceBergen...